The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis

Journal of Investigative Dermatology

Volumn 117, Issue 2, 2001, Pages 333-340

  Raisova, Monika ^a   Hossini, Amir M ^a   Eberle, Jürgen ^a   Riebeling, Christian ^a   Wieder, Thomas ^a   Sturm, Isrid ^a   Daniel, Peter T ^a   Orfanos, Constantin E ^a   Geilen, Christoph C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bax; Bcl 2 ratio; Cd95; Ceramide; Fas; Melanoma

Indexed keywords

BETULIC ACID; CASPASE; CERAMIDE; CYTOCHROME C; DNA FRAGMENT; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; SPHINGOSINE DERIVATIVE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL DEATH; CELL POPULATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MELANOMA CELL; MITOCHONDRION; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0035720233     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01409.x     Document Type: Article

References (48)

1. The Bcl-2 protein family: Arbiters of cell survival
2. Establishment and characterization of human ocular melanoma cell lines
3. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice
4. Cell-mediated cytotoxicity for bladder carcinoma: Evaluation of a workshop
5. Induction of apoptosis by synthetic ceramide analogues in the human keratinocyte cell line HaCaT
6. Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma
7. Cell surface antigens of human malignant melanoma: Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells
8. Mechanisms and consequences of activation of protein kinase B/Akt
9. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
10. Cytotoxic drugs and the CD 95 pathway
11. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors
12. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system
13. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid
14. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells
15. Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells
16. Apoptosis meets signal transduction: Elimination of a BAD influence
17. Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state
18. In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors
19. Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen
20. Daunorubicin-induced apoptosis: Triggering of ceramide generation through sphingomyelin hydrolysis
21. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
22. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
23. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
24. Exceptional lethality for nude mice of cells derived from a primary human melanoma
25. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics
26. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
27. Tumor suppressor p 53 is a direct transcriptional activator of the human bax gene
28. 3
29. The Fas death factor
30. Diversity and complexity of ceramide signalling in apoptosis
31. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
32. Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2-ratio and loss of spontaneous caspase-3 processing in vivo
33. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release
34. Bcl-2 and the regulation of programmed cell death
35. Balancing cell life and death: Bax, apoptosis, and breast cancer
36. Dysregulation of apoptosis in cancer
37. Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma
38. p53 expression is rare in cutaneous melanomas
39. Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
40. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells
41. Analysis of the p53/BAX pathway in colorectal cancer: Low BAX is a negative prognostic factor in patients with resected liver metastases
42. Anti-cell death activity promotes pulmonary metastasis of melanoma cells
43. Expression of apoptosis regulators in cutaneous malignant melanoma
44. Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis
45. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction
46. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine
47. Conformational and functional study of magainin 2 in model membrane environments using the new approach of systematic double-D-amino acid replacement
48. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked